Top 50 Biotechnology Startup Investors in Germany (June 2026)

Portfolio highlights

• QphoX — QphoX builds quantum modem device, connecting quantum computers across a quantum network.
• Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
• BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.

Portfolio highlights

• ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
• Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
• Centauri Therapeutics — At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.

Portfolio highlights

• GermanSubCo — Vulcan Energie Ressourcen GmbH ("GermanSubCo") is the primary German holding subsidiary of Vulcan Energy Resources. It focused on lithium extraction combined with geothermal renewable energy production in the Upper Rhine Valley.
• Power Finance Corporation — Power Finance provides financial products and related advisory, and other services to the power sector in India. It offers fund based financial policies/products, including asset acquisition; bridge, corporate, short term, and rupee and foreign currency term loans; short term loan for SPV; buyer’s line of credit; and credit facility forpurchase of power. Power Finance's fund based financial policies/products also include debt refinancing; energy saving projects; fuel supply projects and equipment manufacturers financing; grants/interest free loans for studies/consultancies; lease financing for wind power projects and purchase of equipment; line of credit for import of coal; takeout financing; and solar PV policy to private sector. Its non-fund based products comprise guarantee, guarantee for credit enhancement, and letter of comfort. Power Finance also provides consultancy services in the areas of procurement of power by distribution licensees; renewable and non-conventional energy schemes; selection of developers for coal blocks; selection of EPC contractors; reform, restructuring, and regulatory aspects; capacity building and human resource development; and execution of ultra-mega power projects, and independent transmission projects. It serves state electricity boards, state power utilities, central power sector utilities, power departments, equipment manufacturers, private power sector utilities, joint sector power utilities, and other state departments engaged in the development of power projects. Power Finance began operation in 1986. It has its headquarters in New Delhi in India.
• Grenergy Renovables — Entwicklung von Photovoltaik und Speicher Projekten und Speicher Projekten mit Grenergy. Willkommen bei Grenergy

Portfolio highlights

• NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
• GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
• Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain

Portfolio highlights

• OMMM — OMMM Operations Management Solutions is a software house that specializes in the digitization and automation of industrial planning.
• Cellbox Solutions — Cellbox Solutions is a young technology company that focuses on innovative logistic solutions for the global BioMed industry.
• Emergence Therapeutics — Emergence Therapeutics is a European biopharmaceutical company developing novel antibody-drug conjugates (ADC) to treat high-need cancers. Its lead program combines a highly specific antibody with optimized linker and payload technology to target Nectin-4 – an important target for a broad range of cancers which has been clinically validated as anADC target by enfortumab vedotin, now approved for the treatment of urothelial cancers by the US Food and Drug Administration. Emergence is also actively exploring opportunities to develop further first- or best-in-class ADCs driven by therapeutic need.

Portfolio highlights

• CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
• XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
• ProGlove — ProGlove makes award-winning wearable wireless barcode scanners using BLE or RF technology for ergonomic and efficient hands-free workflows.

Portfolio highlights

• In.hub — in.hub is a specialist in condition monitoring of machines, processes, and products, offering digitalisation options in the industrial environment. It connects legacy and modern systems, creates condition monitoring systems, and generates information for optimal planning and control.
• Packwise — Packwise is bringing Intermediate Bulk Containers (IBCs) to the Internet of Things. Their Packwise Smart Cap makes a container intelligent and allows for improved and automated packaging management and logistics. Millions of IBCs are being used by chemical, pharmaceutical and food companies every day. Their Packwise Smart Cap is narrow-band LPWANconnected and provides users with real-time information on the state and location of containers.Packwise develops ready-to-use web applications and can be integrated with existing in-house IT or software through web service API.Packwise GmbH is a German company based in the Silicon Saxony. Packwise is Europe’s pioneer in digital industrial packaging management (IBCs and drums).
• HandsOn Robotics —

Portfolio highlights

• PL BioScience — STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
• Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
• traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!

Portfolio highlights

• nyra health — myReha is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. myReha was founded in 2020 and was headquartered in Vienna, Austria.
• UiPath — Reinvent your workplace with the leading robotic process automation platform and learn how UiPath can help your company become a fully automated enterprise.
• UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.

Portfolio highlights

• Vaximm — Vaximm is focused on developing active immunotherapies (vaccines) for patients suffering from cancer. Their initial product candidate VXM01 is targeting the tumor vasculature, which is essential for tumors to grow beyond microscopic size. Vaximm has shown impressive anti-tumor activity in various animal studies and will enter first human clinicaltrials in 2011.
• iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
• Affimed — At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim toovercome the limitations and challenges faced by current immuno-oncology (I-O) therapies.

Portfolio highlights

• mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
• Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
• DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.

Portfolio highlights

• Streaming21 — Streaming21 is a solution provider of seamless on-demand and IP broadcasting service platform for connected digital home.
• Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
• Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.

Portfolio highlights

• Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
• Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
• Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

Portfolio highlights

• F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
• Noema Pharma — DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
• Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.

Portfolio highlights

• Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
• Solar Materials — SOLAR MATERIALS developed a recycling technology for solar modules, which recovers all raw materials for a circular solar industry.
• Litherm Technologies — Litherm Technologies GmbH is a German deep‑tech startup focused on decarbonizing lime and cement production using fully electric kiln technology.

Portfolio highlights

• Altavo — Altavo operates as a medical device startup. Altavo harness the power of machine learning and state-of-the-art sensor technology to improve the lives of people who have lost their voice.
• Leapter — Leapter is the trust engine for AI agents. Build logic tools for AI Agents and de-risk your AI workflows with visual, executable blueprints for deterministic decisions.
• Influnate — Influnate is a tool that allows you to send and receive money via social media. Influnate enables users in social networks to “send and receive money easily, securely and quickly”. This can be done with a comment, a link, or via the Influnate web application. “Redirects to paid websites are a thing of the past,” said the startup.

Portfolio highlights

• Cleafy — A new era for online fraud management: Cleafy combines in real-time all the most advanced fraud detection technologies in one fraud management solution.
• VisioLab — Instantly scan products for self-checkout, using the iPad camera - no barcodes needed. Designed for speed, simplicity and human centricity.
• QuoIntelligence — Our finished intelligence will significantly reduce your operational risks and allow you to make informed security decisions.

Portfolio highlights

• Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
• Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
• Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.

Portfolio highlights

• EcoG — EcoG connects and enables monetizing charging infrastructure with an API-software platform. EcoG is the first cloud-based platform to enable shared revenue streams and value-added services in fast charging. With EcoG a personalized and customized EV fast charging experience is easy to implement and operate.
• IDnow — IDnow provides advanced machine-learning technology for its Identity-as-a-Service platform that can verify identities in real time. The company's solutions guarantee legal security throughout Europe and the highest level of data security. The company provides a legally secure solution without additional hardware in the area of videoidentification of customers and electronic signatures.The company's offer is directed at all business customers who would like to provide customer identification and contract conclusion online, such as banks, telecommunications companies, Fintechs, etc. Its customer portfolio includes renowned firms such as Commerzbank, UBS, Sixt neuwagen, Telefónica, and N26.IDnow was founded on 2014 and is headquartered in Munich, Germany.
• DRACOON GmbH — Every company faces the challenge of storing, managing and sharing data digitally and securely. With our highly secure and platform-independent enterprise file service, we offer our customers maximum flexibility - and at the same time a 100% GDPR-compliant solution. This gives the world back its sovereignty over its data. Our solution DRACOON isthe market leader in the field of enterprise filesharing in the German-speaking area. We live, act and develop according to the principle "Privacy by Design". Our service has already been named as a "Leader" by independent top analysts such as ISG. But also various certificates and seals such as ISO27001 and EuroPriSe rattest DRACOON’s highest security standards. With our service we integrate ourselves deeply into the company processes and thus deliver a maximum protected cocoon for your data - and every connected application. These companies already trust DRACOON: KfW, Rossmann, Helios Kliniken, Rödl & Partner, ElringKlinger, EbnerStolz, DATEV, Nürnberger Versicherung, Thyssen Steel, Deutsche Telekom, Hutchison, Bechtle and many more.

Portfolio highlights

• Seqstant — Seqstant offers the LiveGene platform for real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
• k2-mobility — Operators of heavy vehicle fleets are facing one of the most significant transformational challenges by switching to electric vehicles. The additional time for battery charging, the limited vehicle range as well as diligent planning of energy consumption need to be dynamically integrated and accounted for in their daily operations. K2Mobility's software PANION has a real-time connection to the transport and tour plans, to the vehicles, the chargers and the grid and is planning and optimizing charging for operational excellence, energy cost and Total Cost of Ownership.
• Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.

Portfolio highlights

• SkillYoga — Get a personal yoga training plan based on your goals and experience. Functional, down-to-earth yoga training: anytime, anywhere. Become a better athlete today!
• Likeminded — Likeminded developed a digital platform for mental health that gives people fast, low-threshold access to psychological support.
• BOOST Thyroid — Hashimoto's and hypothyroid app. Empowering people with an underactive thyroid to take full control of their own health. Learn more about underactive thyroid on BOOST's website, with articles including the latest research and advice on thyroid health and autoimmunity.

Portfolio highlights

• SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
• CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
• Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.

Portfolio highlights

• Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
• iSTAR Medical — iSTAR Medical is a medtech company delivering breakthrough eye care solutions through minimally-invasive implants with bio-integration.
• HotSpot Therapeutics — HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspotstructures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.

Portfolio highlights

• Filuta AI — Operationalized Composite Artificial Intelligence
• Resistell AG — Resistell is a antibiotic resistance test.
• iThera Medical — Explore optoacoustic imaging technology for non-invasive in vivo visualization and quantification of disease-related tissue biomarkers.

Portfolio highlights

• Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
• Aware — Aware is a mobile app for evaluating health data and for researching chronic diseases.
• Nostos Genomics — Our genetic variant interpretation platform enables genetic testing labs to give more people with genetic diseases a clear and fast diagnosis.

Portfolio highlights

• GYANT — Create more capacity to care. Fabric is the care enablement system powering healthcare to move faster, work smarter, and deliver better care.
• XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
• Mister Spex — Mister Spex is an online store that sells various brands of glasses and contact lenses in Germany. Its product range includes over 5000 different glasses, sunglasses, sports eyewear, and contact lenses from more than 60 brands and designers.The store’s offerings include sports labels such as Adidas, Carrera, Lacoste, and Oakley to designer brandssuch as Burberry, Calvin Klein, Dolce&Gabbana, Gucci, Jil Sander, Prada, Roberto Cavalli, Tom Ford, and Versace.Mister Spex was launched in 2007 and its operations are headquartered in Berlin, Germany. It also operates its own websites in France, Spain, Austria, Switzerland, the Netherlands, and Great Britain.

Portfolio highlights

• miacosa — miacosa.de is operated by the Endorsed Goods GmbH. miacosa.de is a social shopping concept from Germany based in Cologne. Social Shopping the miacosa way means that members select their personal shopping team of experts and celebrities that present products they love on miacosa.de Miacosa is for members only. The free service starts with productsfrom the fields of Health Style, Home & Living, Kitchen and fashion accessories.
• Hemovent — ​​​Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop aninnovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.
• aquila biolabs — aquila biolabs is a German technology company focusing on the development of innovative laboratory devices for the analysis of shake-flask fermentations in biotechnological, chemical and pharmaceutical research and development.

Portfolio highlights

• ChemInnovation — Molecules from Spectra - For a World without UnknownsAs ChemInnovation, we work on innovative & tailored AI-solutions for analytical chemistry. Within our first years as a company, we were able to bring our intelligent software METIS to researchers and partners within renowned chemical companies. Our smart software METIS accelerates theresearch and development of our customers. Therefore, it empowers them to accelerate their research, understand their chemistry and make their products safer. To achieve this, we have developed our own chemically inspired AI models and smart algorithms, which we now use to automatically evaluate complex data. We combine know-how from the chemical and computer science worlds thereby translating results from academia into productive cloud-software.
• Circus Group — At Circus, we believe cooking should be a loved hobby but not a daily necessity. Driven by the mission to fuel people's busy every day we are building a radically more convenient, sustainable, and affordable solution in food delivery. Circus was established in 2021 in Hamburg, Germany.
• Rock Tech Lithium — Rock Tech Lithium Inc. is a mineral exploration company focused on the lithium industry. Based in Vancouver and listed on the TSX Venture Exchange and the Frankfurt Stock Exchange, the Company’s international board of directors provides a truly global presence and offers unique access to capital and projects.The Company holds an interest in theGeorgia Lake lithium project in the Thunder Bay Mining District of Ontario. The Georgia Lake project consists of approximately 80 leases and approximately 20 claims covering approximately 4,590hectares. The project is located in an area underlain by metasediments and metavolcanics of Archaen age. The Georgia Lake pegmatites contain lithium-bearing spodumene. The spodumene-bearing pegmatites of the Georgia Lake area are located approximately 140 kilometers northeast of the city of Thunder Bay.

Portfolio highlights

• repath — Our mission is to make climate risks visible to companies worldwide in order to enable a resilient and future-proof world.
• SKYSEED — Mit Drohnen und Saatpellets
• Enzo — Enzo is a Heidelberg based InsurTech startup offering modern and smart insurance coverage for homeowners. Instead of just reacting to claims, Enzo takes a proactive customer-focused approach to prevent damages from happening at all. Thus, Enzo is leading a paradigm shift in a €100+ billion market that has barely improved customer experience forover 100 years. Our Goal is to become Europe's smartest homeowners insurance.

Portfolio highlights

• ENOUGH — ENOUGH makes protein sustainable by producing ABUNDA mycoprotein, made by fermenting fungi with the natural sugars from grains. It is a whole protein with all 9 essential amino acids & rich in fibre. It is a B2B ingredient, neutral in taste and fibrous in texture, like meat. The most sustainable
• Change Bio — Change Bio converts waste methane into proteins to make them more affordable and carbon-negative.
• Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.

Portfolio highlights

• Chemify — Digitising Chemistry and Chemical Discovery
• Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
• Visolis — Visolis, a bioengineering company, develops carbon-negative and sustainable chemicals. Its systems approach integrates innovations in synthetic biology, chemical catalysis, and process scale-up to enable new bio-based manufacturing platforms. Visolis' bio-based process helps in achieving true carbon negative chemical synthesis. It beganoperation in 2012, with its headquarters in Berkeley in California.

Portfolio highlights

• Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
• ImCheck Therapeutics — ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
• Greywolf Therapeutics — Novel antigen modulation technology that controls T cells to guide the immune system

Portfolio highlights

• Unmind — Unmind is a workplace mental health platform. We empower employees to measure, understand, and improve their mental wellbeing.
• Handshake — The largest expert network for learning, earning, and growing careers in the AI economy, giving everyone an accessible first step into an AI-powered career.
• Standard Cognition — Standard Cognition is an artificial intelligence platform that allows buyers to grab what they want without having to go to a cashier. It empowers consumers to shop and pay without waiting in line, scanning or stopping to check out. Available to any retailer, the solution helps reduce labor costs, improve the customer experience, and improve profitmargins. It also helps small-size retailers to compete with larger chains and online offerings.Standard Cognition was founded in 2017 and is based in San Francisco, California.

Portfolio highlights

• Innolume — Innolume has invented a novel comb laser light engine for short-reach optical interconnects between and within computers. Economical wavelength-division multiplexing (WDM) is enabled by this class of low-cost, low-power Fabry-Perot lasers. WDM, familiar from telecom, provides an efficient alternative to multiple lasers and underutilized parallelfiber/waveguides, reducing short-reach system cost and power.
• Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
• Scienion — SCIENION AG is a life science company well positioned in the markets of ultra-low volume liquid handling systems and microarray technologies. They provide their customers with an integrated product portfolio facilitating and improving multiparallel bioanalytics, high throughput screening and high throughput production of microarrays in the genomicsand proteomics fields – from early research to manufacturing.

Portfolio highlights

• Okami Medical — Okami Medical is a medical device company with a mission to address the evolving needs of patients and physicians through the development of innovative, versatile, and intuitive devices for the occlusion of peripheral vessels.
• ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
• Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.

Portfolio highlights

• Elio — Putting leading scientific data into context, to enable others to respond to climate change’s dynamism and act on solutions with confidence.
• Ocean Ledger — Precision analytics to design, implement & monitor coastal mitigation and adaptation.
• NatureMetrics — NatureMetrics is the World-Leading provider of Biodiversity monitoring data, using eDNA surveys, metabarcoding & more. Book your demo today!

Portfolio highlights

• Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
• Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
• Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer

Portfolio highlights

• IonKraft — IonKraft's barrier coating technology for plastic packaging, offers excellent product protection while being 100% recyclable.
• Eeden — Eeden engages in the manufacture and supply of textiles.
• Planted Green — Planted Green plants mixed forests to compensate for CO2 emissions.

Portfolio highlights

• LiveEO — LiveEO is the leading solution provider for AI-powered satellite-based monitoring of large infrastructure networks. Trusted worldwide.
• Buynomics — buynomics is the leading solution to optimize your product portfolio. Our clients use buynomics to optimize pricing, promotions, & portfolio architecture.
• HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.

Portfolio highlights

• Surgify — Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa).
• ATRO Medical — ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise hascreated the base for the Trammpolin design and the development towards a prototype.
• microDimensions — microDimensions provides digital pathology software and services: image analysis, 3D histology reconstruction, protein multiplexing, stereology, image registration.

Portfolio highlights

• Younikat — VEGDOG - vegan dog food is the first 100% vegetable and gluten-free complete feed for dogs, which was developed in a one-year development phase in cooperation with specialist veterinarians and specialist laboratories due to a feed allergy in our dog Nelson.
• ecoLocked — ecoLocked is your partner to create a climate-positive built environment. We develop CO2-optimized recipes for concrete based on carbon-negative biochar admixes. Our admixes allow to store captured CO2 in buildings, reduce direct emissions from concrete production, and provide multiple functional benefits, such as improved thermal insulation.
• ProteinDistillery — ProteinDistillery: The Future of Sustainable Protein Production. We transform industrial side-streams into functional protein ingredients.

Portfolio highlights

• Mote — Mote is creating new gasification technologies to produce cost-competitive carbon-negative hydrogen. We offer hydrogen at scale with our uniquely integrated gasification plant.
• CREW Carbon — CREW Carbon is on a mission to remove CO2 across Earth's water cycle by first leveraging wastewater systems as a scalable, deployable solution today. We empower the global wastewater sector to lead the fight against climate change.
• Chloris Geospatial — Chloris Geospatial is able to provide answers today to critical natural capital issues. Chloris Geospatial provides innovative measurements of natural capital that use cutting-edge remote sensing, machine learning, and ecological science.

Portfolio highlights

• tolingo — tolingo is one of the most renowned and successful translation agencies in Germany – a fact which motivates us in our work across every division of our company every day and helps drive us to constantly improve the services we offer to our clients. A human touch is crucial, whether in terms of our employees’ respectful, open interaction with oneanother at our headquarters in Hamburg, our consultations and service meetings with our clients, or the close, productive working relationships we enjoy with our specialist translators and industry experts all over the world. We strive for collaborative success and partnerships on equal footing without losing sight of the expectations we’ve set for ourselves or the standards and goals we’re determined to meet. This is how we’ve been able to transform from a little translation agency into a globally present provider with a sophisticated portfolio of services – with market-leader status in our sights.
• Rodos BioTarget — Rodos BioTarget (RBT) is a biopharmaceutical company developing a targeted drug delivery platform. RBT’s patented TargoSphere® technology enables carrying a broad range of active agents selectively into the center of the immune response - i.e., directly into antigen-presenting cells.RBT currently applies its TargoSphere® technology successfullyin various models of infectious diseases caused by viruses like HCV/ Hepatitis C and HIV/ AIDS and by bacteria like in Tuberculosis, Legionellosis, and MRSA. Yet, any disorder that goes along with either overshooting or insufficient immunity caused by antigen-presenting cells - like chronic inflammations, cancers, allergies, and autoimmune diseases - may be addressed by RBT’s TargoSphere® technology.
• Intelligent Apps — In 2009 founders Niclaus Mewes and Sven Kuelper launched "mytaxi" - the first taxi app with a direct connection between passenger and driver. mytaxi has grown to the fastest growing taxi-app with more than 7 million downloads and 35.000 connected taxis. mytaxi is available in over 40 German cities as well as Washington, Madrid, Barcelona,Warsaw, Vienna, Graz, Salzburg and Zurich. Investors include T-Venture Holding GmbH (Deutsche Telekom AG), Daimler Mobility Services GmbH (Daimler AG), KfW, e42 GmbH and Lars Hinrichs (Cinco Capital GmbH).mytaxi brings a demand for quality to the taxi service for the first time. Every driver using mytaxi has the ability to become a contractor and build their own client base by consistently providing passengers with good service and earning high customer ratings. Through the given peer-to-peer connection between passenger and driver the whole ordering process becomes very transparent for both. The passenger can not only track the taxi’s arrival in the app but also see which driver is coming. For the driver the cost modell is very attractive as they only pay for a successfully completed trip.The aim of mytaxi is to drive the concept of urban mobility and to further strengthen its position as an international leader in this field. Accordingly to that mytaxi took over the app development services for Daimler Mobility Services GmbH (Daimler AG).

Portfolio highlights

• Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
• heybooster — Heybooster is a provider of analytical tools to ecommerce companies to take better digital marketing decisions.
• Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios

Portfolio highlights

• Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
• Naga — NAGA is disrupting the worlds of trading and investment by making them more open and inclusive. It is the single solution that's got it all: Trade, Earn, Invest, Acquire, Connect, Pay; all in one seamless and unified ecosystem that is radically social! Traders and investors from all around the world can use the NAGA technology every day inmany powerful ways: invest in the financial markets (physical stocks, CFDs in stocks, indices, currencies, energies, metals, commodities and cryptocurrencies), make payments in fiat and cryptocurrency, learn about wealth as well as communicate and connect with like-minded people anywhere and anytime. NAGA expands the one-of-a-kind experience with many other unique and innovative services such as the NAGA Mastercard, the AI-driven Portfolio baskets, the world’s first messenger where traders can exchange ideas and opinions in its public channels, Auto-Copying other traders and copying trading signals thanks to the revolutionary NAGA Signals feature.NAGA is really greater than the sum of its parts and powerful when its full spectrum of products and features are used together.
• Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.

Portfolio highlights

• Flair — Smart climate control in every room. Wireless smart thermostats and Smart Vents for Central Heating & AC, Mini Splits, Window ACs, Nest, Ecobee, and more
• Quilt — Quilt is the best home climate system available. Our electric, energy efficient heat pump uses smart technology to save homeowners money and cut emissions.
• Zap Energy — Zap Energy's fusion reactor stabilizes plasma using sheared flows rather than magnetic fields. Driving electric current through the flow creates the magnetic field, which confines and compresses the plasma. The higher the current, the greater the pressure and density in the plasma. Zap Energy's reactor is the least expensive, mostcompact, most scalable solution with the shortest path to commercially viable fusion.

Portfolio highlights

• Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
• Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
• Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.

Portfolio highlights

• Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
• Onego Bio — Onego Bio is a cell ag company, specialized in animal-free egg white protein. We produce bioalbumen with an innovative precision fermentation process.
• Liberation Bioindustries — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.

Portfolio highlights

• Definiens — Definiens is the provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived fromother sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and supports better decisions in research, diagnostics and therapy. Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients’ lives. Definiens is headquartered in Munich, Germany, and has offices throughout the United States.
• Lamab Biologics — Lamab Biologics operates as a biotechnology company. Lamab Biologics develop first-in-class monoclonal antibody prophylactic therapeutic targeting IgE, a key mediator for allergic diseases.
• Rapid Micro Biosystems — Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to RapidMicro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.

Portfolio highlights

• Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
• Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
• Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.